The Status of Acellular Pertussis Vaccines: Current Perspective

PEDIATRICS ◽  
1991 ◽  
Vol 88 (2) ◽  
pp. 401-405
Author(s):  

Clinical studies of component ("acellular") pertussis vaccines have been undertaken in recent years, and several acellular vaccines have been used in Japan for 10 years. The Committee has reviewed these trials and related data and herein provides its assessment regarding the current status of the acellular vaccines and their possible use in the United States. The pertussis vaccines in current use in the United States are prepared from whole cells of a strain of Bordetella pertussis that is grown in broth medium, harvested by centrifugation, and killed or partially detoxified by heat or by the addition of a chemical agent, such as thimerosal, or by a combination of these methods. In contrast, the acellular vaccines developed in Japan and used in that country since 1981 contain one or more antigens derived from biologically active components of the B pertussis organism.1 An inactivated form of lymphocytosis promoting factor (LPF), also known as pertussis toxin and a variety of other synonyms, is a frequent component of acellular pertussis vaccines, as are filamentous hemagglutinins (FHA). Other constituents included in acellular vaccines are agglutinogens, a term denoting a variety of protein antigens on the surface of the B pertussis organism. Of the agglutinogens, a 69-kd outer membrane protein, when injected into neonatal mice, protects against B pertussis challenge.2 Acellular vaccines also have recently been derived from mutant pertussis toxin molecules prepared with recombinant DNA technology.3 The acellular vaccines produced in Japan have been classified into two types: B type, which contains LPF and FHA in roughly equal amounts; and T type, which contains mostly FHA but some LPF and agglutinogens.1,4

2001 ◽  
Author(s):  
Winfred M. Phillips

Abstract The National Institutes of Health (NIH) defines bioengineering as an interdisciplinary field that applies physical, chemical, and mathematical sciences and engineering principles to the study of biology, medicine, behavior, and health. Bioengineering advances knowledge from the molecular to the organ systems level, and develops new and novel biologics, materials, processes, implants, devices, and informational approaches for the prevention, diagnosis, and treatment of disease, for patient rehabilitation, and for improving health. Enormous contributions to the advancement of health care have been made through bioengineering. It has been instrumental in establishing the United States as the world leader in health care technology, as evidenced by a $4.6 billion trade surplus for this sector in 1993. The field, through basic and applied research and technology assessment, has given us such devices as the pacemaker, orthopedic implants, and noninvasive diagnostic imaging. Bioengineers have developed new processes for manufacturing products in the pharmaceutical and biotechnology industries. An example is the manufacturing of human insulin, the first product based on recombinant DNA technology, where bioengineering was critical to the ability to commercialize the product. These continuing contributions and unprecedented growth, focus, and opportunity in bioengineering will be a continuing frontier and opportunity for the United States and the world.


1969 ◽  
Vol 15 (3) ◽  
Author(s):  
Henry Miller

The largest outbreak of food-borne illness in a decade sickened over 1400 people in various parts of the United States in 2008. Originally thought to be caused by tomatoes contaminated with Salmonella saintpaul, an investigation by federal agencies found that Mexican jalapeno peppers and possibly serrano peppers were the culprits.These sorts of outbreaks are not at all rare: A search for ‘food poisoning’ on the website of the US Centers for Disease Control and Prevention (CDC) (on 10 November 2008) yielded more than 5300 hits, and the CDC estimates that each year 76 million cases of food-borne illness occur and more than 300 000 persons are hospitalised and 5000 die. This raises various questions of importance to consumers. Who or what is responsible for the problem? How does such contamination occur, and what can be done to prevent recurrences?Unfortunately, growers of fresh produce cannot protect us 100 per cent of the time. Modern farming operations – especially the larger ones – already employ strict standards and safeguards designed to keep food free of pathogens. And most often they’re highly effective: Americans’ food is not only the least expensive but also the safest, in the history of humankind.The vast majority of food poisoning results from consumers’ improper handling of food – in particular, from inadequately cooking chicken or permitting the juices from raw poultry to contaminate other foods.Because agriculture is an outdoor activity and subject to myriad unpredictable challenges, there are limits to how safe we can make it. If the goal is to make a cultivated field completely safe from microbial contamination, the only definitive solution is to pave it over and build a parking lot on it. But we’d only be trading very rare agricultural mishaps for fender-benders.Nor can we rely on processors to remove the pathogens from food in every case. The 2006 spinach-based outbreak of illness served as a reminder that our faith in processor labels such as ‘triple washed’ and ‘ready to eat’ must be tempered with at least a little scepticism. Processors were quick to proclaim the cleanliness of their own operations and deflect blame toward growers. But all of those in the food chain share responsibility for food safety and quality.In fairness to processors, there is ample evidence to suggest that no amount of washing will rid produce entirely of all pathogens. The reason is that the contamination may occur not on the plant, but in it. Exposure to Salmonella, E. coli or other microorganisms at key stages of the growing process may allow them to be introduced into the plant's vascular system.In the longer term, technology has an important role – or more accurately, it would have if only the organic food advocates and other activists would permit it. The Food and Drug Administration recently added fresh spinach and iceberg lettuce to the short list of foods that companies can irradiate to kill off many dangerous pathogens. (Regulators had already approved irradiation of meat, poultry, spices, oysters, clams and mussels.) Food irradiation is an important, safe and effective tool that has been vastly under-used, largely due to opposition from the organic food lobby. Their resistance is scandalous – and murderous: ‘If even 50% of meat and poultry consumed in the United States were irradiated, the potential impact of food borne disease would be a reduction [of] 900,000 cases and 300 deaths’, according to Michael Osterholm, Director of the Center for Infectious Disease Research at the University of Minnesota.But irradiation is not a panacea. Although it quite effectively kills the bacteria, it does not inactivate the potent toxins secreted by certain bacteria such as Staphylococcus aureus and Clostridium botulinum, and the approved doses are too low to kill most viruses. The toxins can cause serious illness or death even in the absence of live bacteria themselves.There is technology available today that can both inhibit microorganisms’ ability to grow within plant cells and block the effects of the biochemical and structural features that enable bacteria to cause disease. This same technology can be employed to produce antibodies that can be administered to infected patients to neutralise toxins and other harmful molecules and can even be used to produce therapeutic proteins (such as lactoferrin and lysozyme) that are safe and effective treatments for diarrhoea, the primary symptom of food poisoning.But organic producers won’t embrace this triple-threat technology, even if it would keep their customers from food-borne illness. The technology in question is recombinant DNA technology, or gene-splicing (also known as ‘genetic modification’, or GM) – an advance the organic lobby has repeatedly vilified and rejected.For organic marketers and food activists, the irony is more bitter than fresh-picked radicchio. The technology that offers a potent new weapon to assure the safety of foods is the one they’ve fought hardest to forestall and confound.In view of the huge burden of illnesses and deaths caused by bacteria and viruses in food, will the organic lobby rethink their opposition to biotechnology? Will they begin to appreciate the ways in which this technology can save lives and advance their industry? Will they permit science, common sense and decency to trump ideology? When figs can fly.


2019 ◽  
Vol 02 (03) ◽  
Author(s):  
Sherif Aly ◽  
Allan Stolarski ◽  
Patrick O’Neal ◽  
Edward Whang ◽  
Gentian Kristo

Harmful Algae ◽  
2021 ◽  
pp. 101975
Author(s):  
Donald M. Anderson ◽  
Elizabeth Fensin ◽  
Christopher J. Gobler ◽  
Alicia E. Hoeglund ◽  
Katherine A. Hubbard ◽  
...  

Author(s):  
Mohammad Reza Davahli ◽  
Krzysztof Fiok ◽  
Waldemar Karwowski ◽  
Awad M. Aljuaid ◽  
Redha Taiar

The COVID-19 pandemic has had unprecedented social and economic consequences in the United States. Therefore, accurately predicting the dynamics of the pandemic can be very beneficial. Two main elements required for developing reliable predictions include: (1) a predictive model and (2) an indicator of the current condition and status of the pandemic. As a pandemic indicator, we used the effective reproduction number (Rt), which is defined as the number of new infections transmitted by a single contagious individual in a population that may no longer be fully susceptible. To bring the pandemic under control, Rt must be less than one. To eliminate the pandemic, Rt should be close to zero. Therefore, this value may serve as a strong indicator of the current status of the pandemic. For a predictive model, we used graph neural networks (GNNs), a method that combines graphical analysis with the structure of neural networks. We developed two types of GNN models, including: (1) graph-theory-based neural networks (GTNN) and (2) neighborhood-based neural networks (NGNN). The nodes in both graphs indicated individual states in the US states. While the GTNN model’s edges document functional connectivity between states, those in the NGNN model link neighboring states to one another. We trained both models with Rt numbers collected over the previous four days and asked them to predict the following day for all states in the USA. The performance of these models was evaluated with the datasets that included Rt values reflecting conditions from 22 January through 26 November 2020 (before the start of COVID-19 vaccination in the USA). To determine the efficiency, we compared the results of two models with each other and with those generated by a baseline Long short-term memory (LSTM) model. The results indicated that the GTNN model outperformed both the NGNN and LSTM models for predicting Rt.


2016 ◽  
Vol 214 (1) ◽  
pp. S339-S340
Author(s):  
Dotun Ogunyemi ◽  
Alma Aurioles ◽  
Rob Olson ◽  
Nathaniel Sugiyama ◽  
Ray Bahado-Singh

1993 ◽  
Vol 57 (2) ◽  
pp. 424
Author(s):  
H. Lee Stribling ◽  
John J. Mayer ◽  
I. Lehr Brisbin

2005 ◽  
Vol 16 (07) ◽  
pp. 410-418 ◽  
Author(s):  
Dennis Van Vliet

The members of the profession of audiology often express concern that the services and products that have been developed to provide benefit to the hearing impaired are not sought after or delivered to the majority of those diagnosed with hearing loss. A critical look at the status quo of hearing care delivery in the United States is needed to verify this assumption and to develop strategies to improve the situation. A key concern is the lack of a comprehensive high-quality scientific database upon which to build continuous improvements in the effectiveness of the services and products that are provided to the hearing impaired.


Urology ◽  
2014 ◽  
Vol 84 (4) ◽  
pp. 743-747 ◽  
Author(s):  
Bruce Slaughenhoupt ◽  
Oreoluwa Ogunyemi ◽  
Maria Giannopoulos ◽  
Christina Sauder ◽  
Glen Leverson

Sign in / Sign up

Export Citation Format

Share Document